ClearPoint Neuro CLPT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 62.3%+1.0pp | 61.4%+0.1pp | 61.3%+0.9pp | 60.4%-0.8pp | 61.2%+0.3pp | |
| Operating margin | -65.2%+0.2pp | -65.4%+0.9pp | -66.3%+1.1pp | -67.4%-0.1pp | -67.3%-4.4pp | |
| Net margin | -71.6%-2.5pp | -69.1%-1.7pp | -67.4%-1.2pp | -66.2%-1.6pp | -64.5%-4.3pp | |
| EBITDA margin | -63.2%-0.1pp | -63.2%+0.8pp | -63.9%+0.5pp | -64.4%+0.3pp | -64.7%-4.9pp | |
| Free cash flow margin | -65.7%+0.4pp | -66.1%-25.8pp | -40.3%-5.4pp | -34.9%+1.5pp | -36.4%-7.0pp | |
| Returns | ||||||
| Return on equity | -149.7%-54.1pp | -95.6%+7.5pp | -103.1%-17.5pp | -85.7%-9.5pp | -76.2%+5.0pp | |
| Return on assets | -47.1%-9.8pp | -37.3%+8.7pp | -46%-7.5pp | -38.5%+11.2pp | -49.7%-3.5pp | |
| Return on invested capital | -93%+7.4pp | -100.4%+86.6pp | -187%-16.7pp | -170.3%+8.8pp | -179.2%+10.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.5×-0.1× | 0.7×+0.1× | 0.6×-0.2× | 0.8×0.0× | |
| Inventory turnover | 3.5×+0.2× | 3.4×-0.5× | 3.9×-0.2× | 4.1×-68.6× | 72.7×+22.5× | |
| Liquidity | ||||||
| Current ratio | 5.8×-0.1× | 5.9×-0.5× | 6.4×-0.9× | 7.3×+3.8× | 3.5×+0.3× | |
| Quick ratio | 4.9×-0.2× | 5.1×-0.4× | 5.6×-0.9× | 6.4×+2.9× | 3.5×+0.3× | |
| Cash ratio | 3.9×-0.5× | 4.4×-0.4× | 4.8×-0.9× | 5.6×+3.8× | 1.8×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 3.4×+1.3× | 2.1×-0.2× | 2.3×+0.5× | 1.8×+1.6× | 0.2×0.0× | |
| Debt-to-assets | 0.7×+0.1× | 0.6×0.0× | 0.6×0.0× | 0.6×+0.4× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $0.64-35.6% | $0.99+77.2% | $0.56-20.1% | $0.70-3.1% | $0.72-23.2% | |
| Valuation | ||||||
| Market capitalization | $538.61M+69.2% | $406.96M-34.3% | $619.43M+88.4% | $328.72M+0.1% | $328.55M-22.6% | |
| Enterprise value | $565.68M+82.9% | $418.22M-32.2% | $616.78M+91.3% | $322.46M+0.9% | $319.6M-21.6% | |
| Price / sales | 13.3×+3.4× | 11×-7.0× | 18×+8.3× | 9.8×-0.4× | 10.2×-3.3× | |
| Price / book | 28.6×+12.7× | 14.5×-24.5× | 39×+22.4× | 16.7×+0.2× | 16.4×-0.3× | |
| EV / sales | 13.9×+4.3× | 11.3×-6.7× | 18×+8.4× | 9.6×-0.3× | 9.9×-3.1× | |
| Free cash flow yield | -5%-1.3pp | -6%-3.8pp | -2.2%+1.3pp | -3.6%0.0pp | -3.6%-1.4pp | |
| Earnings yield | -5.4%+1.1pp | -6.3%-2.5pp | -3.7%+3.0pp | -6.8%-0.4pp | -6.3%-1.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ClearPoint Neuro's profit margins?
- ClearPoint Neuro (CLPT) runs a 62.3% gross margin and a -65.2% operating margin, with a -71.6% net margin.
- Where do ClearPoint Neuro's ratios come from?
- Every ratio is computed from ClearPoint Neuro's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
